共 613 条
[1]
Bullinger L(2017)Genomics of acute myeloid leukemia diagnosis and pathways J Clin Oncol 35 934-946
[2]
Dohner K(2012)The prevalent predicament of relapsed acute myeloid leukemia Hematol Am Soc Hematol Educ Progr 2012 43-48
[3]
Dohner H(2010)Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial J Clin Oncol 28 586-595
[4]
Szer J(2017)Acute myeloid leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Cancer Netw 15 926-957
[5]
Burnett AK(2013)Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia N Engl J Med 368 2059-2074
[6]
Hills RK(2012)Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia J Clin Oncol 30 4515-4523
[7]
Milligan DW(2016)Diagnosis and therapy of acute myeloid leukemia in the era of molecular risk stratification Annu Rev Med 67 59-72
[8]
Goldstone AH(2016)Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia Blood 128 686-698
[9]
Prentice AG(2016)Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group Leukemia 30 2248-2250
[10]
McMullin MF(2019)Targeting FLT3 mutations in AML: review of current knowledge and evidence Leukemia 33 299-312